Nursing Elites

1. What is the primary use of Bromocriptine?

• A. Relieve constriction ring.
• B. Manage post-partum hemorrhage.
• C. Affect milk production.
• D. Be used in pre-eclampsia.

Correct answer: C

Rationale: Bromocriptine is primarily used to affect milk production. It is a medication commonly prescribed to help suppress lactation, particularly in cases of postpartum breast engorgement or when stopping breastfeeding. Choices A, B, and D are incorrect as Bromocriptine is not indicated for relieving constriction ring, managing post-partum hemorrhage, or treating pre-eclampsia.

2. Which of the following is not a barrier method of birth control?

• A. Vaults
• B. Diaphragms
• C. Sterilization
• D. Cervical caps

Correct answer: C

Rationale: The correct answer is C, Sterilization. Sterilization is a permanent form of birth control that involves surgical procedures to prevent pregnancy by blocking the fallopian tubes or vas deferens. Barrier methods physically prevent sperm from reaching the egg, such as vaults, diaphragms, and cervical caps. These devices create a barrier to sperm, unlike sterilization. Therefore, choices A, B, and D are all considered barrier methods of birth control.

3. Which of the following is NOT a phase of the menstrual cycle?

• A. Follicular phase
• B. Ovulatory phase
• C. Luteal phase
• D. Secretory phase

Correct answer: D

Rationale: The secretory phase is not considered a distinct phase of the menstrual cycle; it is actually part of the luteal phase. During the luteal phase, the endometrium thickens due to progesterone secretion, preparing for implantation. The follicular phase is characterized by follicle development, leading to ovulation. The ovulatory phase is when the mature egg is released from the ovary. Therefore, the secretory phase is the correct answer as it is not a standalone phase but a part of the luteal phase.

4. Discuss the anatomical/physiological changes in pregnancy under the following: Uterus

• A. The uterus softens in the anterior midline, becomes flexible at the uterocervical junction, blood vasculature increases in size and number, and hypertrophy of myometrial cells occurs.
• B. The uterus decreases in size during pregnancy and remains rigid.
• C. The uterus size remains unchanged, and no changes occur in the blood vasculature.
• D. Uterus becomes more rigid and hypertrophies.

Correct answer: A

Rationale: During pregnancy, the uterus undergoes various anatomical and physiological changes. The correct answer, Choice A, accurately describes these changes. The uterus softens in the anterior midline, becomes flexible at the uterocervical junction, experiences an increase in blood vasculature size and number, and myometrial cells hypertrophy. This softening and increased vascularity are essential for accommodating the growing fetus and facilitating delivery. Choices B, C, and D are incorrect because they do not reflect the typical changes that occur in the uterus during pregnancy. The uterus does not decrease in size, remain unchanged in size, become more rigid, or hypertrophy without the described softening and vascular changes.

5. Which one of the following is not associated with poor maternal outcome?

• A. APH
• B. PPH
• C. Cord prolapse
• D. Pre-eclampsia

Correct answer: C

Rationale: Cord prolapse is not typically associated with poor maternal outcomes. Acute placental hemorrhage (APH - choice A) and postpartum hemorrhage (PPH - choice B) can lead to maternal morbidity and mortality due to excessive blood loss. Pre-eclampsia (choice D) is a serious pregnancy complication characterized by high blood pressure and signs of damage to other organ systems, which can result in severe maternal complications if not managed promptly. Cord prolapse, though concerning for fetal well-being, does not inherently pose direct risks to maternal health if managed appropriately, making it the correct answer in this context.

Similar Questions